Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series.

JD Cohen, I Bournerias, V Buffard, A Paufler… - The Journal of …, 2007 - jrheum.org
OBJECTIVE: Although tumor necrosis factor-alpha (TNF-alpha) antagonists are effective in
the treatment of refractory psoriasis, some cases have suggested that psoriasis might be …

Hidradenitis suppurativa (HS): an unrecognized paradoxical effect of biologic agents (BA) used in chronic inflammatory diseases

…, F Aubin, D Lipsker, M Bottaro, JD Cohen… - Journal of the American …, 2016 - Elsevier
Background Paradoxical hidradenitis suppurativa (HS) induced by biologic agents (BA) is
scarcely reported. Objective We sought to describe the clinical characteristics and outcome of …

Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study

…, F Aubin, PD Ghislain, JD Cohen… - Journal of the …, 2014 - pubmed.ncbi.nlm.nih.gov
… 6 , Jean-David Cohen

Patients' information and perspectives on biosimilars in rheumatology: a French nation-wide survey

L Frantzen, JD Cohen, S Tropé, M Beck, A Munos… - Joint Bone Spine, 2019 - Elsevier
Objective To assess the patients' information about biosimilars and to identify the patients’
incentives and deterrents to concur with the use of biosimilars. Methods Nation-wide cross-…

Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data.

…, V Farrenq, A Marini-Portugal, JD Cohen… - The Journal of …, 2005 - jrheum.org
OBJECTIVE: To report early experience of switching anti-tumor necrosis factor-a (TNF-alpha)
therapy from infliximab to etanercept in patients with spondyloarthropathy (SpA) and …

Health assessment questionnaire score is the best predictor of 5-year quality of life in early rheumatoid arthritis.

JD Cohen, M Dougados, P Goupille… - The Journal of …, 2006 - jrheum.org
OBJECTIVE: To evaluate and determine prognostic factors of 5-year quality of life in patients
with early rheumatoid arthritis (RA). METHODS: A cohort of 191 patients with RA and …

Estimation of the Bath Ankylosing Spondylitis Disease Activity Index cutoff for perceived symptom relief in patients with spondyloarthropathies.

JD Cohen, P Cunin, V Farrenq, O Oniankitan… - The Journal of …, 2006 - jrheum.org
OBJECTIVE: To estimate the best Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
cutoff based on patients' perceptions of symptom relief collected in a large population of …

Relevance and feasibility of a systematic screening of multimorbidities in patients with chronic inflammatory rheumatic diseases

…, MC Picot, A Jaussent, F Roubille, JD Cohen… - Joint Bone Spine, 2019 - Elsevier
Objectives EULAR recently proposed to screen multimorbidities in chronic inflammatory
rheumatic diseases. The aims of the study were to define the most common multimorbidities in …

Essential knowledge for patients with rheumatoid arthritis or spondyloarthritis: Results of a multicentric survey in France among health professionals and patients

…, P Coquerelle, T Pham, D Poivret, JD Cohen… - Joint Bone Spine, 2019 - Elsevier
Objective Information and education are recommended for patients with inflammatory
arthritis including rheumatoid arthritis (RA) and spondyloarthritis (SpA). However, there is no …

Sarcoidosis induced by tocilizumab: a paradoxical event?

A Nutz, C Pernet, B Combe, JD Cohen - The Journal of Rheumatology, 2013 - jrheum.org
A 40-year-old woman of North African origin had RA for 12 years. Rheumatoid factor and
anticitrullinated antibody were negative. Erosions were absent. Nevertheless, she fulfilled the …